Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.60 -0.62 (-3.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Return on Capital Employed [ROCE] (2016 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) posted Return on Capital Employed [ROCE] of -39.75% for Q2 2026, up 27.33 percentage points from -67.08% a year earlier and up 14.11 percentage points from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends

For FY2025, Syndax Pharmaceuticals' Return on Capital Employed [ROCE] came in at -53.85%, up 6.24 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -10.08 percentage points (FY2020 to FY2025).
  • In prior years, Syndax Pharmaceuticals' Return on Capital Employed [ROCE] was -60.09% in FY2024 (-13.82 pp), -46.27% in FY2023 (-12.12 pp), -34.15% in FY2022 (-41.55 pp) and 7.40% in FY2021 (+51.16 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of -1.35 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2021, with a gain of 40.40 percentage points; the weakest was Q3 2023, with a drop of 47.75 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -53.86% (Q1 2026), -64.92% (Q4 2025) and -66.75% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Syndax Pharmaceuticals 1.57 Bn -160.92 Mn 69.58 Mn -39.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -39.75%
Mar 31, 2026 -53.86%
Dec 31, 2025 -64.92%
Sep 30, 2025 -66.75%
Jun 30, 2025 -67.08%
Mar 31, 2025 -58.47%
Dec 31, 2024 -72.00%
Sep 30, 2024 -81.94%
Jun 30, 2024 -61.60%
Mar 31, 2024 -49.98%
Dec 31, 2023 -51.33%
Sep 30, 2023 -51.60%
Jun 30, 2023 -41.61%
Mar 31, 2023 -35.38%
Dec 31, 2022 -38.00%
Sep 30, 2022 -3.86%
Jun 30, 2022 0.30%
Mar 31, 2022 4.08%
Dec 31, 2021 8.10%
Sep 30, 2021 -40.16%
API Access

Syndax Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNDX&period=max&api_key=YOUR_API_KEY